Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Todd D. Wiener who wrote (209)	1/10/1998 8:13:00 PM
From: Del Holmes	Read Replies (1) \| Respond to of 783

Estimates were calling for .17 for the fourth quarter, so who knows what will happen if it comes in at .16. Last quarter they missed the estimate by three cents and we're still reeling. Biochem still strikes me as a pretty good investment, but it's really been kicked around for the last couple of months, and most of the reasons have very little to do with the company or its product ... currency, bombings, Asia, etc. One of these days people have to begin to realize that this is pretty good little company.